Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Ex vivo Purging

Resveratrol selectively inhibits leukemia cells: a prospective agent for ex vivo bone marrow purging

Bone Marrow Transplantation volume 25, pages 639–645 (2000)Cite this article

Abstract

Ex vivo purging of contaminating tumor cells may reduce the incidence of relapse in patients undergoing bone marrow transplantation. In this study we demonstrate that resveratrol, a phytoalexin with anti-oxidant and chemopreventive activity, exhibits anti-leukemic activity against mouse (32Dp210, L1210) and human (U937, HL-60) leukemic cell lines by inhibiting cell proliferation. Long-term exposure to resveratrol also inhibits the clonal growth of normal hematopoietic progenitor cells but at a higher IC50 of resveratrol than that for most of the leukemia cell lines tested. The inhibitory effect of resveratrol on hematopoietic progenitors is partially reversible, whereas the effect on leukemia cells is largely irreversible. The inhibition of leukemia cells by resveratrol involves nucleosomal DNA fragmentation (apoptosis). On the other hand, resveratrol does not induce or enhance spontaneously occurring apoptotic death in normal hematopoietic progenitor cells. In vivo experiments performed with untreated and resveratrol-treated bone marrow showed comparable hematopoietic reconstitution in lethally irradiated mice (10 Gy) as determined by survival, hematologic recovery, and the number of hematopoietic progenitor cells present in the marrow of reconstituted animals. Taken together, these results indicate the potential use of resveratrol for ex vivo pharmacological purging of leukemia cells from bone marrow autografts without significant loss in the hematopoietic activity of progenitor cells. Bone Marrow Transplantation (2000) 25, 639–645.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  1. Vesole DH, Jagannath S, Glenn L, Barlogie B . Auto transplantation in multiple myeloma Hematol Oncol 1993 7: 613–630

    CAS  Google Scholar 

  2. Petersen FB, Lynch MHE, Clift RA et al. Autologous bone marrow transplantation for patients with acute myeloid leukemia in untreated first relapse or in second complete remission J Clin Oncol 1993 11: 1353–1360

    Article  CAS  Google Scholar 

  3. Deisseroth AB, Zu Z, Claxton D et al. Genetic marking shows that ph+ cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML Blood 1994 83: 3068–3076

    CAS  PubMed  Google Scholar 

  4. Brenner MK, Rill DR, Moen RC et al. Gene-marking to trace origin of relapse after autologous bone marrow transplantation Lancet 1993 341: 85–86

    Article  CAS  Google Scholar 

  5. Rill DR, Santana VM, Roberts WM et al. Direct demonstration that autologous bone marrow transplantation for solid tumors can return a multiplicity of tumorigenic cells Blood 1994 84: 380–383

    CAS  PubMed  Google Scholar 

  6. Gribben JG, Arnold MD, Freedman AS et al. Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma New Engl J Med 1991 325: 1525–1533

    Article  CAS  Google Scholar 

  7. Brugger W, Bross KJ, Glatt M et al. Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors Blood 1994 83: 636–640

    CAS  PubMed  Google Scholar 

  8. Yeager AM, Kaizer H, Santos GW et al. Autologous bone marrow transplantation in patients with acute nonlymphocytic leukemia using ex vivo marrow treatment with 4-hydroxycyclophosphamide New Engl J Med 1986 315: 141–147

    Article  CAS  Google Scholar 

  9. Jones RJ . Purging with 4-hydroperoxycyclophosphamide J Hematother 1992 1: 343–348

    Article  CAS  Google Scholar 

  10. Laporte JP, Douay L, Lopez M et al. One hundred twenty-five adult patients with primary acute leukemia autografted with marrow purged with mafosamide: A 10 year single institution experience Blood 1994 84: 3810–3818

    CAS  PubMed  Google Scholar 

  11. Gulati SC, Acaba L, Yahalom J et al. Autologous bone marrow transplantation for acute myelogenous leukemia using 4 hydroperoxycyclophosphamide and VP-16 purged bone marrow Bone Marrow Transplant 1992 10: 129–137

    CAS  PubMed  Google Scholar 

  12. Gorin NC, Aegerter P, Auvert B et al. Autologous bone marrow transplantation for acute myelocytic leukemia in first remission: a European survey of the role of marrow purging Blood 1990 75: 1606–1614

    CAS  PubMed  Google Scholar 

  13. Belguendouz L, Fremont L, Gozzelino MT . Interaction of transresveratrol with plasma lipoproteins Biochem Pharmacol 1998 15: 811–816

    Article  Google Scholar 

  14. Frankel EN, Waterhouse AL, Kinsella JE . Inhibition of human LDL oxidation by resveratrol Lancet 1993 341: 1103–1104

    Article  CAS  Google Scholar 

  15. Pace-Asciak CR, Hahn S, Diamandis EP et al. The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: implications for protection against coronary heart disease Clin Chim Acta 1995 235: 207–219

    Article  CAS  Google Scholar 

  16. Rotondo S, Rajtar G, Manarini S et al. Effects of trans-resveratrol, a natural polyphenolic compound, on human polymorphonuclear leukocyte function Br J Pharmacol 1998 123: 1691–1699

    Article  CAS  Google Scholar 

  17. Kimura Y, Okuda H, Arichi S . Effects of stilbenes on arachidonate metabolism in leukocytes Biochim Biophys Acta 1985 834: 275–278

    Article  CAS  Google Scholar 

  18. Belguendouz L, Fremont L, Linard A . Resveratrol inhibits metal ion-dependent and independent peroxidation of porcine low-density lipoproteins Biochem Pharmacol 1997 53: 1347–1355

    Article  CAS  Google Scholar 

  19. Bertelli AA, Giovannini L, Bernini W et al. Antiplatelet activity of cis-resveratrol Drugs Exp Clin Res 1996 22: 61–63

    CAS  PubMed  Google Scholar 

  20. Jang M, Cai L, Udeani GO et al. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes Science 1997 275: 218–220

    Article  CAS  Google Scholar 

  21. Mgbonyebi OP, Russo J, Russo IH . Antiproliferative effect of synthetic resveratrol on human breast epithelial cells Int J Oncol 1998 12: 865–869

    CAS  PubMed  Google Scholar 

  22. Jayatilake GS, Jayasuria H, Lee HS et al. Kinase inhibitors from poly gonum cuspidatum J Nat Prod 1993 56: 1805–1810

    Article  CAS  Google Scholar 

  23. Synold TW, Doroshow TW . Resveratrol, a phenolic constituent of wine inhibits topoisomerase II and induces apoptosis in human leukemia cells Proc Am Assoc Cancer Res 1998 39: 422 (Abstr.)

    Google Scholar 

  24. Clement MV, Hirapa JL, Chawdhury SH, Pervaiz S . Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells Blood 1998 92: 996–1002

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We are grateful to Drs Alfonso Scicli and Howard Haspel for critical review of this paper and Cindy Bonwell for her expert secretarial support. This work was supported by the Van Patrick Cancer Research Fund and a grant from the Elsa U Pardee Foundation.

Author information

Authors and Affiliations

  1. Division of Hematology/Oncology, Department of Medicine, Henry Ford Health System, Detroit, Michigan, USA

    SC Gautam, YX Xu, M Dumaguin, N Janakiraman & RA Chapman

Authors
  1. SC Gautam
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. YX Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M Dumaguin
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. N Janakiraman
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. RA Chapman
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gautam, S., Xu, Y., Dumaguin, M. et al. Resveratrol selectively inhibits leukemia cells: a prospective agent for ex vivo bone marrow purging. Bone Marrow Transplant 25, 639–645 (2000). https://doi.org/10.1038/sj.bmt.1702189

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1702189

Keywords

This article is cited by

Search

Advanced search

Quick links